No evidence for cell activation or brain vaso-occlusion with plerixafor mobilization in sickle cell mice

scientific article published on 21 December 2015

No evidence for cell activation or brain vaso-occlusion with plerixafor mobilization in sickle cell mice is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.BCMD.2015.12.008
P932PMC publication ID4806642
P698PubMed publication ID26852658

P50authorNarla MohandasQ80363825
Karina YazdanbakhshQ96036318
P2093author name stringHenny H Billett
Craig Branch
Erika Choi
Min-Hui Cui
Patricia A Shi
P2860cites workFlk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cellsQ24555063
Neutrophil adhesion and activation under flowQ33775782
Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonistQ34412254
Hematopoietic stem cell mobilization for gene therapy of adult patients with severe β-thalassemia: results of clinical trials using G-CSF or plerixafor in splenectomized and nonsplenectomized subjectsQ35665207
The emerging value of P-selectin as a disease markerQ35808636
Pathology of Berkeley sickle cell mice: similarities and differences with human sickle cell diseaseQ35848672
Hematopoietic stem cell mobilization for gene therapy: superior mobilization by the combination of granulocyte-colony stimulating factor plus plerixafor in patients with β-thalassemia majorQ37208384
Granulocyte colony-stimulating factor (G-CSF) administration in individuals with sickle cell disease: time for a moratorium?Q37354296
Mobilized peripheral blood grafts include more than hematopoietic stem cells: the immunological perspectiveQ38349208
Decreased cerebral perfusion correlates with increased BOLD hyperoxia response in transgenic mouse models of sickle cell diseaseQ47990049
Increased platelet aggregation and in vivo platelet activation after granulocyte colony-stimulating factor administrationQ60189998
Alterations in L-selectin expression and elastase activity in neutrophils from patients receiving granulocyte colony-stimulating factor alone or in conjunction with high-dose chemotherapy with autologous bone marrow transplantationQ71685889
Middle cerebral artery velocity changes during transfusion in sickle cell anemiaQ72841744
A new form of Filgrastim with sustained duration in vivo and enhanced ability to mobilize PBPC in both mice and humansQ73370268
Kinetics of CXCR-4 and adhesion molecule expression during autologous stem cell mobilisation with G-CSF plus AMD3100 in patients with multiple myelomaQ80164759
P921main subjectsickle-cell diseaseQ185034
P304page(s)67-70
P577publication date2015-12-21
P1433published inBlood Cells, Molecules and DiseasesQ15758051
P1476titleNo evidence for cell activation or brain vaso-occlusion with plerixafor mobilization in sickle cell mice
P478volume57